GT Biopharma Net Non-Operating Interest Income Expense (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.8139 -0.11 (-11.54%) USD | NASDAQ | Dec 30, 16:00

0.82 +0.01 (+0.75%) Pre-Market: 08:20

View Net Non-Operating Interest Income Expense (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade
Plus Therapeutics, Inc.	Upgrade
Geron Corp.	Upgrade